Vnitr Lek 2026, 72(3):183-186 | DOI: 10.36290/vnl.2026.038

The relationship between atrial fibrillation and dementia

Petra Kratochvílová
II. interní klinika FN Plzeň

Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia worldwide and currently affecting approximately 2-4 % of the population. Its prevalence continues to rise, and by around 2050, the number of patients with AF is expected to approach 100 million (1). Dementia currently affects 5-7 % of individuals over the age of 60, and its prevalence is projected to triple by 2050 (2). This disease leads to loss of independence, increased need for long-term care, and higher overall mortality. In recent years, accumulating evidence has suggested an association between AF and an increased risk of cognitive decline and dementia. The aim of this review is to summarize the most recent epidemiological data, pathophysiological mechanisms, and preventive strategies underlying this relationship, based on published studies. Available data confirm that AF, particularly when diagnosed in midlife, significantly increases the risk of both overall and early-onset dementia. Careful control of cardiovascular risk factors and adequate treatment may reduce this risk.

Keywords: atrial fibrillation, dementia, anticoagulation.

Accepted: April 23, 2026; Published: May 18, 2026  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kratochvílová P. The relationship between atrial fibrillation and dementia. Vnitr Lek. 2026;72(3):183-186. doi: 10.36290/vnl.2026.038.
Download citation

References

  1. Saglietto A, Matta M, Gaita F, et al. Association of catheter ablation and reduced incidence of dementia among patients with atrial fibrillation: A systematic review and meta-analysis. JACC Clin Electrophysiol. 2022;8(12):1421-30.
  2. Rodríguez-García J, Sánchez E, López-Medina G, et al. Association between atrial fibrillation and dementia in a large population-based study in southern Europe. Rev Esp Cardiol. 2025;78(5):421-431.
  3. Ding M, Qiu C. Atrial Fibrillation, Cognitive Decline, and Dementia: an Epidemiologic Review. Curr Epidemiol Rep. 2018;5(3):252-261. Go to original source... Go to PubMed...
  4. Bansal N, Zelnick LR, An J, et al. Incident atrial fibrillation and risk of dementia in a diverse, community-based population. J Am Heart Assoc. 2023;12(6):e028290. Go to original source... Go to PubMed...
  5. Giannone ME, Magnani S, Paternoster M, et al. Atrial Fibrillation and the Risk of Early-Onset Dementia: A Systematic Review and Meta-Analysis. J Am Heart Assoc. 2022;11(13):e025653. Go to original source... Go to PubMed...
  6. Åkerström F, Charitakis E, Paul-Nordin A, et al. Reduced dementia risk in patients with optimized anticoagulation therapy undergoing atrial fibrillation ablation. Heart Rhythm. 2024;21(9):1487-1492. Go to original source... Go to PubMed...
  7. Wood KA, Han F, Ko YA, Wharton WW. Is the association between cognitive disease progression and atrial fibrillation modified by sex? Alzheimers Dement. 2023;19(9):4163-4173. Go to original source... Go to PubMed...
  8. Fong KY, Chan YH, Wang Y, et al. Dementia Risk of Direct Oral Anticoagulants Versus Warfarin for Atrial Fibrillation: Systematic Review and Meta-Analysis. JACC Asia. 2023;3(5):776-786. Go to original source...
  9. Ruff CT, Giugliano RP, Braunwald E, et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet. 2014;383(9921):955-962. Go to original source... Go to PubMed...
  10. Elango K, Javaid A, Khetarpal BK, et al. The Effects of Warfarin and Direct Oral Anticoagulants on Systemic Vascular Calcification: A Review. Cells. 2021;10(4):773. Go to original source... Go to PubMed...
  11. Fox KAA, Lucas JE, Pieper KS, et al. Improved risk stratification of patients with atrial fibrillation: an integrated GARFIELD-AF tool for the prediction of mortality, stroke and bleed in patients with and without anticoagulation. BMJ Open. 2017;7(12):e017157. Go to original source... Go to PubMed...
  12. Ding P, Chen W, Shen J, et al. Incidence of silent cerebral lesions during pulsed field ablation for paroxysmal atrial fibrillation. Ann Med. 2026;58(1):2634472. Go to original source... Go to PubMed...
  13. Müller P, Halbfass P, Szöllösi A, et al. Impact of periprocedural anticoagulation strategy on the incidence of new-onset silent cerebral events after radiofrequency catheter ablation of atrial fibrillation. J Interv Card Electrophysiol. 2016;46(3):203-211. Go to original source... Go to PubMed...
  14. Häusler KG, Eichner FA, Heuschmann PU, et al. MRI-Detected Brain Lesions and Cognitive Function in Patients With Atrial Fibrillation Undergoing Left Atrial Catheter Ablation in the Randomized AXAFA-AFNET 5 Trial. Circulation. 2022;145(12):906-915. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.